US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Beta Bionics, Inc.
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
September 29, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
September 22, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
September 17, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
September 15, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock
September 15, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
September 14, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
July 29, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
July 01, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
June 02, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
May 21, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Present at the Bank of America Securities Health Care Conference
April 27, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
April 21, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
March 31, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
March 30, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
February 19, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026
February 17, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
January 15, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
January 08, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
December 08, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Participation at Upcoming Investor Conferences
November 03, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
October 28, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
October 09, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Participation at Upcoming Investor Conferences
August 21, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
July 29, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
July 02, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
June 19, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
May 06, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Present at the Bank of America Securities Health Care Conference
May 01, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
April 16, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
Beta Bionics to Host Investor Event on June 22, 2025
April 09, 2025
From
Beta Bionics, Inc.
Via
GlobeNewswire
Tickers
BBNX
